The Veles Group delivers integrated scientific and regulatory expertise to help organizations solve complex challenges with clarity and confidence. Our team combines strengths in pharmaceutical development, biotechnology, toxicology, exposure and risk modeling, and geology/geophysics to provide targeted, decision‑ready insights that accelerate product development, strengthen compliance, and support strategic growth.
We analyze critical threats to human and ecological well‑being arising from chemical, biological toxin, and infectious disease exposures. Our work evaluates how these hazards affect population health and ecosystem stability, providing clear, evidence‑based insights that support policy, regulatory, and organizational decision‑making.
Expertise spanning CGT platform development, BA/BE and SUPAC‑SS strategy, IND‑enabling design, assay and quality and compliance systems. We help teams accelerate development, strengthen regulatory readiness, and solve complex scientific challenges.
Analysis of seismology, gravity, magnetic, electrical surveys and use of GIS technology to explore resources, support energy production, hydrology, and monitor natural hazards.
We provide high‑resolution scientific and regulatory analysis through white papers, technical reports, executive summaries, and visual briefings. Our integrated teams work across disciplines to deliver full evidence syntheses that illuminate complex scientific and regulatory landscapes, as well as focused assessments that resolve niche challenges, inform compliance strategies, and advance program, product, or organizational objectives.
Our consulting model combines deep scientific expertise with trusted networks across academia, government, and industry. We assemble the right experts for your project and guide the process from start to finish, ensuring transparency, rigor, and results that directly support your needs and objectives.
The Veles Group may responsibly apply the technology for limited purposes such as editing and formatting documents, identifying source information, or enhancing visuals created by our experts. We continually monitor the evolution of genAI technologies and will adapt our policies as needed—always guided by the strongest ethical, legal, security, and scientific standards.
At The Veles Group, we are committed to helping our clients understand and navigate both the opportunities and challenges of generative artificial intelligence (genAI). We can provide evidence-based guidance on implementing genAI effectively—and on how this technology may impact your organization, stakeholders, or constituents.
Generative AI is a powerful tool, but it comes with well-documented logical, legal, ethical, and regulatory risks. For this reason, The Veles Group does not use genAI to generate technical deliverables for clients, with the exceptions noted above. While the technology is impressive, it cannot replace human expertise, context, and innovation. In fact, genAI is prone to significant challenges, including:
Every product we deliver is crafted and reviewed by scientific experts in their respective fields, then undergoes additional quality assurance by The Veles Group to ensure it meets the highest professional standards. Our clients can rely on us for information and recommendations that are unbiased, evidence-based, and rigorously validated.
